Exterior of the William Henry Duncan Building

Our facilities

We have invested £20m in state-of-the-art research facilities. This infrastructure was used extensively in Liverpool’s Covid-19 response and was central to the nation’s research capabilities as exemplified by the International Severe Acute Respiratory and Emerging Infection Coronavirus Clinical Characterisation Consortium (ISARIC-4C) Consortium.

Liverpool has National Institute for Health Research (NIHR) antimicrobial resistance (AMR) laboratories, which are Good Clinical Practice (GCP) compliant and with significant bioanalytical, pathogen sequencing and pharmacogenomic capabilities. This regulated infrastructure also provides access to clinical research facilities (CRFs) at partner NHS Trusts. Liverpool shared research facilities (LIV-SRF) offer a joint resource for multi-omics, bioimaging and bioresources, which are further complemented by activity within the Centres for Genomic Research, Proteomics and Metabolomics Research.

Data and health informatics capabilities are provided through the Liverpool City Region Civic Data Cooperative (CDC), bringing data, analytic teams, patients/public/practitioners and researchers into a critical mass of informatics activity across NHS, university, local authority and industry organisations.

Back to: Centre of Excellence in Infectious Diseases Research (CEIDR)